Plain-English translation of NCT07537153 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a procedure called Genicular Artery Embolization (GAE) for people with mild-to-moderate knee osteoarthritis who haven't found relief from conservative treatments like pain medications. During the procedure, a doctor inserts a thin tube (catheter) into an artery and uses tiny particles to reduce blood flow to the inflamed tissue surrounding the knee joint. The goal is to see if this treatment can safely reduce knee pain and improve how well your knee works.
Knee osteoarthritis affects millions of people, and many don't get enough relief from standard treatments like medications or physical therapy. This procedure offers a new option that may help reduce pain by calming the inflammation in the knee without major surgery, but doctors need to confirm it's safe and truly effective.
You likely qualify if…
You likely don't qualify if…
You'll start with a screening visit where doctors review your medical history, examine your knee, take an x-ray, and ask you questions about your pain. Then you'll receive the GAE procedure, which involves sedation and a catheter placed in an artery to deliver tiny particles to reduce blood flow around the knee. After that, you'll have follow-up visits at regular intervals—several within the first year, then visits at year 2 and year 3—where doctors check your knee, update your medications, and ask how your pain and function have improved. Some visits can be done remotely.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United States